Sera from patients with systemic lupus erythematosus (SLE) and other connective tissue diseases have been demonstrated to contain a variety of antinuclear antibodies. Antibodies to native DNA appear to be present only in sera from patients with clinically active SLE. These antibodies have been detected by a variety of techniques, such as precipitation in agar (Seligmann, 1957) , complement fixation (Ceppellini, Polli, and Celada, 1957; Robbins, Holman, Deicher and Kunkel, 1957) , immunofluorescence (Friou, Finch and Detre, 1958) , and, more recently by the Farr ammonium sulphate precipitation technique (Wold, Young, Tan, and Farr, 1968; Pincus, Schur, Rose, Decker, and Talal, 1969; Hughes, Cohen, and Christian, 1971; Carr, Koffler, Agnello, and Kunkel, 1969) .
At the present time, the laboratory test used most widely in the diagnosis of SLE is the indirect fluorescent antibody test (ANA) in which a source of whole nuclei is used. This technique is extremely sensitive and capable of detecting all antibodies which are directed against nuclear antigens. A variety of patterns of nuclear fluorescence may be observed, such as speckles, diffuse fluorescence of the entire nucleus, and fluorescence of the periphery of the nucleus. The peripheral pattern seems to be limited to sera from patients with clinically active SLE (Casals, Friou, and Teague, 1963; Gonzalez and Rothfield, 1966) , the diffuse pattern is commonly observed in sera from inactive SLE patients and patients with rheumatoid arthritis (Gonzalez and Rothfield, 1966; Hughes and Rothfield, 1970) , and the speckled pattern is found most frequently in sera from patients with progressive systemic sclerosis (Rothfield and Rodnan, 1968) . In addition, sera from elderly individuals and a small percentage of normal subjects may produce either a diffuse or a speckled pattern (Rothfield and Rodnan, 1968; Cammarata, Rodnan, and Fennell, 1967) .
We have previously analysed sera from patients with SLE and demonstrated that complement-fixing antibodies to native DNA or to the DNA ofthe DNAhistone complex are present in sera which produce a peripheral pattern of nuclear fluorescence (Rothfield and Stollar, 1967) .
The present study was performed in an attempt to correlate the pattern of nuclear fluorescence obtained by the indirect fluorescent antibody technique with the level of anti-DNA antibodies obtained by the Farr ammonium-sulphate technique and to evaluate the usefulness of the two methods in the diagnosis and management of patients with SLE.
Materials and methods

PATIENTS
Sera were studied from patients seen at the UniversityMcCook Hospital, the Newington Children's Hospital, Hartford Hospital, New Britain General Hospital, St. Francis Hospital, and Mt. Sinai Hospital. 158 sera were studied from 82 SLE patients in whom the duration of disease ranged from 1 month to 15 years. All had evidence of multiple system disease compatible with SLE and a positive LE-cell preparation at some time during the course of the disease, and fitted the preliminary criteria for the diagnosis of SLE (Cohen, Reynolds, Franklin, Kulka, Ropes, Shulman, and Wallace, 1971 ml. tryptophane, 0-2 per cent. glucose, and 3 ug. per ml. thymidine, then diluted 1:100 and grown overnight in the same medium without thymidine to deplete endogenous pools of thymidine. After diluting again 1:100, the cells were grown to O.D.650 = 0 025. The cells were exposed to 1 0 pc./ml. (3H) thymidine (specific activity 6-7 c./mmol.) at 37°C. and allowed to grow to the stationary phase. Cells were harvested by centrifugation, washed once with 100 ml. 0 15 M saline and re-suspended in 5 ml. 0-01 M tris HCI buffer (pH 7 5) containing 0 75 M sucrose. 0-6 ml. of a lysozyme solution (1 mg. per ml. in 01 tris HCl buffer, pH 7 5) and 12 ml. of 0 0015 M EDTA, pH 8, were added and the mixture was incubated at 37°C. for 15 min. 18 mg. pronase and 0-24 ml. 40 per cent. sodium dodecyl sarcosinate were added to lyse the cells. After incubation at 37°C. for 60 min., 10-7 g. caesium chloride were added to the lysate. Four ml. of the mixture were transferred into each of six tubes containing 8-0 ml. of 60 per cent. caesium chloride in 0O0l M tris HCI buffer, pH 7-5. The final concentration of caesium chloride in the tubes was 1-7 g./cm.3
The tubes were centrifuged at 20°C. for 45 hrs at 33,000 r.p.m. using SW41 rotor. The DNA, which appeared as a sharp band in the middle of the tube, was withdrawn, and dialysed against saline citrate buffer, pH 7 0, for 24 hrs. The final volume of DNA solution recovered was 20 ml. containing 0-3 mg. DNA per ml. The specific activity was 4-35 x 10' counts per minute per ,ug. DNA or 1-3 x 107 c.p.m. per ml. of DNA solution. The concentrations of DNA and protein were determined by the ratio of absorbance at optical density 260 and 280 and the Folin reaction. The native DNA was free of protein.
AMMONIUM-SULPHATE PRECIPITATION TECHNIQUE
The amount of labelled DNA bound by the serum to be tested was determined by the method of Wold and others (1968), using 0 05 ml. serum diluted to 5 ml. in 0 1 M borate saline buffer, pH 8-0, and 0 5 ml. labelled DNA solution diluted to 0-0015 mg. DNA per ml. All sera were tested in duplicate. The DNA-binding activity is expressed as the counts per minute in the precipitate of test serum less the counts per minute precipitated by normal serum divided by total counts in the DNA x 100.
INDIRECT FLUORESCENT ANTIBODY TEST FOR ANA
The test was carried out as previously described using mouse liver as a source of nuclei and fluorescein isothiocyanate labelled anti-IgG (Gonzalez and Rothfield, 1966) . Sera were tested undiluted and the pattern of nuclear fluorescence recorded. The sera were studied without knowledge of the results of the ammonium-sulphate technique.
Results
DNA-BINDING
The results of the ammonium-sulphate technique for DNA-binding is shown in Fig. 1 The mean DNA-binding of the 54 sera producing a peripheral pattern was 70 4 ± 18-2 per cent. (Fig. 2) . Mean values were 32-7 ± 23 per cent. for 167 sera producing a diffuse pattern, 14 ± 12 2 per cent. for 63 sera producing a speckled pattern, and 13-5 ± 7-9 per cent. for 195 sera giving a negative ANA test. SLE sera, which produced a peripheral pattern (mean 70-4 ± 18-2 per cent.) (Fig. 3) activity at the time their serum was obtained. 35 bound more than 40 per cent. of DNA. 61 of 83 sera from patients with clinically active SLE bound more than 40 per cent. ofDNA (P < 0-01). More striking was the correlation between clinical evidence of active renal disease, i.e. haematuria, increasing proteinuria, increasing renal insufficiency, and a high percentage of DNA-binding. As shown in Table I , of 31 sera from patients with active renal disease, 28 had more than 40 per cent. DNA-binding, whereas 69 of 127 sera from patients with inactive renal disease had more than 40 per cent. (P < 0-0005). Less significant correlations of DNA-binding were found for disease activity of joints or of skin.
Discussion
The results confirm the observations of others regarding the value of measuring DNA antibodies in SLE for both diagnostic and management purposes. DNAbinding of more than 50 per cent. was present only in sera from SLE patients and was not present in sera from 172 patients with other connective tissue diseases or in sera from ninety normal individuals. Of the 322 non-SLE sera studied, none bound more than 50 per cent. DNA, six sera bound between 40 and 50 per Hasselbacher and LeRoy (1972) reported findings similar to those described here. These investigators also used bacterial DNA and found that the mean DNA-binding in the sera of forty normal subjects was 18-7 ± 8-6 per cent. In our study, sera from ninety normal individuals were tested and the mean DNAbinding was 15 ± 7-96 per cent. Thus, the use of bacterial DNA seems to lead to a somewhat higher DNA-binding in normal sera than that reported for mammalian DNA.
Previous reports have shown a lower DNA-binding for non-SLE sera (Pincus and others, 1969; Hughes and others, 1971; Carr and others, 1969) . This difference may also be related to the source of DNA, since these investigators have used calf thymus DNA or a human tumour cell line DNA.
The peripheral pattern was present only in sera from patients with SLE. Thus, both the peripheral pattern of nuclear fluorescence and a high DNA-binding are limited to sera from patients with SLE. 
